WallStreetZenWallStreetZen

NASDAQ: LABT
Lakewood Amedex Biotherapeutics Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Lakewood Amedex Biotherapeutics earnings were -$7.3M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest LABT earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$3.8M, up 308.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, LABT reported annual earnings of -$3.8M, with -20.8% growth.

LABT earnings history

Current Revenue
$0.0
Current Earnings
-$7.3M
Current Profit Margin
0%

LABT Return on Equity

Insufficient data to display

LABT Return on Assets

Current Company
-443.7%
Current Industry
-10.2%
LABT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when LABT announces earnings.

LABT Return on Capital Employed

Current Company
-166.77%
Current Industry
-6.7%

LABT vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
LABTN/A-$7.35MN/A-$11.35
LIMN-$12.45M-$12.52MN/A-$23.50
DRMA-$8.37M-$8.37MN/A-$4.39
PHGE-$69.05M-$72.81MN/A-$396.70
PMCB-$19.42M-$23.21MN/A-$2.77
View Top Biotech Stocks

Lakewood Amedex Biotherapeutics Earnings Reports & History FAQ

What were Lakewood Amedex Biotherapeutics's earnings last quarter?

On LABT's earnings call on Aug 28, 2026, Lakewood Amedex Biotherapeutics (NASDAQ: LABT) reported Q2 2026 earnings per share (EPS) of -$2.75, up 65.66% year over year. Total LABT earnings for the quarter were -$3.77 million. In the same quarter last year, Lakewood Amedex Biotherapeutics's earnings per share (EPS) was -$1.66.

If you're new to stock investing, here's how to buy Lakewood Amedex Biotherapeutics stock.

Is Lakewood Amedex Biotherapeutics profitable or losing money?

As of the last Lakewood Amedex Biotherapeutics earnings report, Lakewood Amedex Biotherapeutics is currently losing money. Lakewood Amedex Biotherapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$7.35 million, a 84.32% increase year over year.

What was LABT's earnings growth in the past year?

As of Lakewood Amedex Biotherapeutics's earnings date in Aug 28, 2026, Lakewood Amedex Biotherapeutics's earnings has grown year over year. LABT earnings in the past year totalled -$7.35 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.